1. Home
  2. CINT vs EBS Comparison

CINT vs EBS Comparison

Compare CINT & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$3.35

Market Cap

478.1M

Sector

Technology

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$7.22

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
EBS
Founded
1995
1998
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.1M
413.3M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
CINT
EBS
Price
$3.35
$7.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$7.35
$12.00
AVG Volume (30 Days)
129.0K
656.7K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
0.07
Revenue
N/A
$742,900,000.00
Revenue This Year
$16.69
$1.29
Revenue Next Year
$11.28
N/A
P/E Ratio
$17.94
$103.57
Revenue Growth
N/A
N/A
52 Week Low
$3.03
$5.62
52 Week High
$6.06
$14.06

Technical Indicators

Market Signals
Indicator
CINT
EBS
Relative Strength Index (RSI) 48.90 34.23
Support Level $3.10 N/A
Resistance Level $3.59 $8.59
Average True Range (ATR) 0.15 0.28
MACD 0.03 -0.04
Stochastic Oscillator 53.57 4.17

Price Performance

Historical Comparison
CINT
EBS

About CINT CI&T Inc

CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: